Published Date: 08 Jan 2025
The incidence of in situ breast cancer has decreased since 2009, consistent with decreasing use of mammography in association with the 2009 U.S. Preventive Services Task Force (USPSTF) guideline change, according to a study ...
Read Full NewsEnhancing Comprehensive Biomarker Testing and Biomarker-Directed Treatment Selection
Advancing Care in ES-SCLC: Personalized Strategies, New Therapies, and Real-World Insights
Belzutifan and pembrolizumab together reduced the risk of disease recurrence or death
Capivasertib plus abiraterone combination lands indication for PTEN-deficient tumors
"Combinations represent additional options for early-line treatment," researcher says
The bispecific T-cell engager also reduced toxicity in newly diagnosed kids
A combination of clinician and patient prompts worked best, but talks remained infrequent
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation